VP, Deputy General Counsel

Shari Noble

Shari has more than 20 years’ experience in the biopharmaceutical industry supporting all stages of drug development as well as corporate governance and public company reporting activities.

Prior to joining Atea, Shari served in positions of increasing responsibility at Radius Health, Inc. from 2015 to 2020, most recently as Assistant General Counsel. Prior to that she held roles of increasing responsibility, including Director and Senior Counsel, Corporate Contracting & Global R&D at Cubist Pharmaceuticals, Inc., from 2003 through a 4-month transition following the acquisition by Merck & Co. in 2015.

Shari earned a BA in English and American Literature from the University of California, San Diego and a JD from the University of Pittsburgh.

Back to Full Team